- Home
- MDGL vs TFX Comparison
MDGL vs TFX Comparison
Compare MDGL & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- TFX
- Stock Information
- Founded
- MDGL 2011
- TFX 1943
- Country
- MDGL United States
- TFX United States
- Employees
- MDGL N/A
- TFX N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- TFX Medical/Dental Instruments
- Sector
- MDGL Health Care
- TFX Health Care
- Exchange
- MDGL Nasdaq
- TFX Nasdaq
- Market Cap
- MDGL 9.6B
- TFX 5.5B
- IPO Year
- MDGL N/A
- TFX N/A
- Fundamental
- Price
- MDGL $414.60
- TFX $132.10
- Analyst Decision
- MDGL Strong Buy
- TFX Hold
- Analyst Count
- MDGL 12
- TFX 9
- Target Price
- MDGL $521.09
- TFX $141.57
- AVG Volume (30 Days)
- MDGL 271.9K
- TFX 515.0K
- Earning Date
- MDGL 10-28-2025
- TFX 11-06-2025
- Dividend Yield
- MDGL N/A
- TFX 1.02%
- EPS Growth
- MDGL N/A
- TFX N/A
- EPS
- MDGL N/A
- TFX 4.18
- Revenue
- MDGL $515,547,000.00
- TFX $3,041,342,000.00
- Revenue This Year
- MDGL $394.08
- TFX $10.42
- Revenue Next Year
- MDGL $61.80
- TFX $10.58
- P/E Ratio
- MDGL N/A
- TFX $31.87
- Revenue Growth
- MDGL 3421.98
- TFX 1.11
- 52 Week Low
- MDGL $200.63
- TFX $108.90
- 52 Week High
- MDGL $463.63
- TFX $239.82
- Technical
- Relative Strength Index (RSI)
- MDGL 41.95
- TFX 61.70
- Support Level
- MDGL $418.88
- TFX $118.45
- Resistance Level
- MDGL $445.06
- TFX $129.43
- Average True Range (ATR)
- MDGL 16.53
- TFX 4.04
- MACD
- MDGL -3.65
- TFX 1.03
- Stochastic Oscillator
- MDGL 1.76
- TFX 80.24
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.